Clinical trials for Hairy cell leukaemia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Hairy cell leukaemia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Hairy cell leukaemia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Hairy cell leukaemia
Title Recruitment status Location
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Patients With Relapsed or Refractory Acute Myeloid Leukemia Recruiting United Kingdom
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment Recruiting United Kingdom
An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE Antibody Blinatumomab in Adult Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) Recruiting United Kingdom
Tumor Tissue, Blood Samples, and Family History in Predicting Tumor Development and Response to Treatment in Young Patients With Low-Grade Glioma Recruiting United Kingdom
A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer Recruiting United Kingdom
CARPALL: Immunotherapy With CD19 CAR T-cells for CD19+ Haematological Malignancies Recruiting United Kingdom
An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Recruiting United Kingdom
A Single-arm, Multicenter, Nilotinib Treatment-free Remission Study in Patients With BCR-ABL1 Positive Chronic Myelogenous Leukemia in Chronic Phase Who Have Achieved Durable Minimal Residual Disease (MRD) Status on First Line Nilotinib Treatment. Recruiting United Kingdom
A MULTICENTER, PHASE III, OPEN-LABEL, RANDOMIZED STUDY IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TO EVALUATE THE BENEFIT OF GDC-0199 (ABT-199) PLUS RITUXIMAB COMPARED WITH BENDAMUSTINE PLUS RITUXIMAB Recruiting United Kingdom
Alternative Ofatumumab containing regimens in less fit patients with chronic lymphoid leukemia (CLL) Recruiting United Kingdom

Page last reviewed:

Next review due: